Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carbonic Anhydrase IX”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableStudy completedNCT06309459
What this trial is testing

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma

Who this might be right for
Triple Negative Breast CancerCarbonic Anhydrase IX
Kahramanmaras Sutcu Imam University 40
Not applicableEnded earlyNCT00942058
What this trial is testing

Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Kidney CancerMetastatic Renal Cell Carcinoma
Centre Hospitalier Universitaire de Saint Etienne 16
Early research (Phase 1)Not Yet RecruitingNCT05698238
What this trial is testing

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more
Mabpro, a.s. 50
Not applicableLooking for participantsNCT06519760
What this trial is testing

68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

Who this might be right for
Carbonic Anhydrase IXPET-CTClear Cell Renal Cell Carcinoma
Peking University First Hospital 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07197580
What this trial is testing

Study of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Who this might be right for
ccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 40
Early research (Phase 1)Not Yet RecruitingNCT07260162
What this trial is testing

Evaluation of Safety, Tolerability and Response of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)

Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 24
Not applicableActive Not RecruitingNCT00892866
What this trial is testing

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Who this might be right for
Atypical Endometrial HyperplasiaHuman Papillomavirus InfectionStage 0 Cervical Cancer AJCC v7
GOG Foundation 877
Not applicableLooking for participantsNCT06956144
What this trial is testing

Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

Who this might be right for
TumorCarbonic Anhydrase IX
The First Affiliated Hospital of Xiamen University 113
Early research (Phase 1)Looking for participantsNCT05868174
What this trial is testing

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorAdvanced Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 36
Testing effectiveness (Phase 2)Looking for participantsNCT06447103
What this trial is testing

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer+2 more
Jonsson Comprehensive Cancer Center 91
Testing effectiveness (Phase 2)Ended earlyNCT03450018
What this trial is testing

SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
British Columbia Cancer Agency 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05239533
What this trial is testing

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaKidney CancerAdvanced Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Very early researchStudy completedNCT05728515
What this trial is testing

A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 3
Not applicableUnknownNCT00980759
What this trial is testing

Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer

Who this might be right for
Cervical Cancer
National Cancer Center, Korea 312
Very early researchStudy completedNCT04897763
What this trial is testing

Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC

Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 6
Not applicableLooking for participantsNCT05214885
What this trial is testing

Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Qianfoshan Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07171905
What this trial is testing

CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease

Who this might be right for
VHL - Von Hippel-Lindau Syndrome
IRCCS Ospedale San Raffaele 38
Testing effectiveness (Phase 2)UnknownNCT05902377
What this trial is testing

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking Union Medical College Hospital 46
Testing effectiveness (Phase 2)Study completedNCT04758780
What this trial is testing

Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Institut Cancerologie de l'Ouest 12
Very early researchStudy completedNCT00884520
What this trial is testing

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

Who this might be right for
Lung CancerSquamous Cell CarcinomaHead and Neck Cancer+2 more
Siemens Molecular Imaging 16